Why the study?
There is currently no universally recognized therapeutic protocol for neonatal tachyarrhythmias, particularly in preterm newborns experiencing hypotension during recurrent PSVT despite antiarrhythmic prophylaxis.
Answers are grounded in this paper and cite their sources.
This case report highlights the rare occurrence of relapsing atrial flutter after cardioversion in a preterm newborn and the need for personalized management of resistant hypotension during recurrent SVT.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Valencic et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: